Corporate News-先瑞达医疗科技控股有限公司

About US

About US

Introduction

Our Value

History

Contact Us

Join Us
Patients

Patients

Patients

Peripheral Arterial Disease

Peripheral Arteriosclerosis

Peripheral Venous Disease

Varicosity

Peripheral Arterial Disease

Peripheral Venous Disease

Peripheral Arteriosclerosis

Varicosity
Professional Medical Solutions

Professional Medical Solutions

Products

Peripheral Artery

PTA Catheter

ATK DCB Dilatation catheter

BTK DCB Dilatation Catheter

Support Catheter

Peripheral Cone-shaped Balloon Dilation Catheter

Peripheral Vein

Peripheral Vascular Aspiration System

Endovenous RF Closure System

Second Generation Peripheral Vascular Aspiration S

Maintenance Of Arteriovenous Fistula Access

DCB Dilatation Catheter for Hemodialysis Access

Peripheral Scoring Balloon Dilatation Catheter

Neurovascular

Endocranial Balloon Dilatation Catheter

Coronary Artery

Coronary Artery Balloon Dilatation Catheter

RT-Zero Coronary Artery Balloon Dilatation Cathete

Vericor-14 Microtubule

Academic

Peripheral Artery

Peripheral Vein

Maintenance Of Arteriovenous Fistula Access

Neurovascular

Coronary Artery

PTA Catheter

ATK DCB Dilatation catheter

BTK DCB Dilatation Catheter

Support Catheter

Peripheral Cone-shaped Balloon Dilation Catheter

Peripheral Vascular Aspiration System

Endovenous RF Closure System

Second Generation Peripheral Vascular Aspiration S

DCB Dilatation Catheter for Hemodialysis Access

Peripheral Scoring Balloon Dilatation Catheter

Endocranial Balloon Dilatation Catheter

Coronary Artery Balloon Dilatation Catheter

RT-Zero Coronary Artery Balloon Dilatation Cathete

Vericor-14 Microtubule
News

News

Corporate News

R&D Progress
Investor Relations

News

All Corporate News R&D Progress

Corporate News

Load more information

About US

Patients

Professional Medical Solutions

News

News

Corporate News

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec and Boston Scientific Sign Master Collaboration Agreement and Master Service Agreement

Acotec and Boston Scientific Sign Memorandum of Understanding

Acotec Reports 2022 Annual Results: full-year revenue of $396 million, up 30% year-over-year

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

先瑞达2022中期业绩发布：营收1.75亿元，同比增长25%，增长点多元化

先瑞达发布2021年业绩报告：全年营收3.04亿元，同比增长56.6%，调整后净利润同比增长140.4%

道阻且长行则将至 | 先瑞达2021年终盘点

先瑞达披露2021年年度经营数据预测：年度营收和毛利较去年同比实现大幅增长

先瑞达荣膺格隆汇“年度最具创新力IPO”奖

About US

Patients

Professional Medical Solutions

News

News

Corporate News

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec and Boston Scientific Sign Master Collaboration Agreement and Master Service Agreement

Acotec and Boston Scientific Sign Memorandum of Understanding

Acotec Reports 2022 Annual Results: full-year revenue of $396 million, up 30% year-over-year

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

先瑞达2022中期业绩发布：营收1.75亿元，同比增长25%，增长点多元化

先瑞达发布2021年业绩报告：全年营收3.04亿元，同比增长56.6%，调整后净利润同比增长140.4%

道阻且长 行则将至 | 先瑞达2021年终盘点

先瑞达披露2021年年度经营数据预测：年度营收和毛利较去年同比实现大幅增长

先瑞达荣膺格隆汇“年度最具创新力IPO”奖

道阻且长行则将至 | 先瑞达2021年终盘点